PharVision Advisers’s Rockwell Automation ROK Stock Holding History

PharVision Advisers’s Portfolio ROK Stock Details ROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-647	Closed	-$226K	–	962
2025 Q3	$226K	Sell	647 -191	-23%	-$66K	0.13%	407
2025 Q2	$278K	Buy	+838	New	+$239K	0.4%	97

Other funds holding ROK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's ROK Position: Q4 2025 in Review

PharVision Advisers sold out of Rockwell Automation (ROK) in Q4 2025, closing a stake of 647 shares — an estimated $226K sold.

PharVision Advisers first reported a position in ROK in Q2 2025 and held it in 2 quarters. The position peaked at $278K in Q2 2025. 1,417 funds tracked by Wall St. Rank hold ROK as of Q4 2025.

PharVision Advisers reported no remaining Rockwell Automation position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 647 Rockwell Automation shares in Q4 2025, an estimated $226K.
PharVision Advisers first reported a position in Rockwell Automation in Q2 2025 and held it in 2 quarters.
PharVision Advisers's Rockwell Automation position peaked at $278K in Q2 2025.
1,417 funds tracked by Wall St. Rank held Rockwell Automation as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.